March 24, 2017 7:12 PM ET

Biotechnology

Company Overview of C3J Therapeutics, Inc.

Company Overview

C3J Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of therapeutics aimed at reengineering the human microbiome. The company improves human health through the development and commercialization of targeted or pathogen-specific antimicrobials (STAMPs) that treat and prevent human diseases caused by microbial dysbiosis. It offers STAMP platform technology for targeted antimicrobial therapy and correcting microbial dysbiosis. C3J Therapeutics, Inc. was formerly known as C3 Jian, Inc. and changed its name to C3J Therapeutics, Inc. in November 2016. The company was incorporated in 2005 and is headquartered in Marina del Rey, California.

4503 Glencoe Avenue

Marina del Rey, CA 90292

United States

Founded in 2005

Phone:

310-665-2928

Fax:

310-665-2963

Key Executives for C3J Therapeutics, Inc.

Chief Executive Officer, President and Director
Age: 53
Co-Founder, Founding Scientist and Director
Vice President of Finance & Accounting
Chief Operating Officer
Senior Director of Preclinical Biology
Compensation as of Fiscal Year 2016.

C3J Therapeutics, Inc. Key Developments

C3J Therapeutics, Inc. Presents at 29th Annual ROTH Conference, Mar-14-2017 05:00 PM

C3J Therapeutics, Inc. Presents at 29th Annual ROTH Conference, Mar-14-2017 05:00 PM. Venue: The Ritz Carlton, Laguna Niguel, Dana Point, California, United States.

C3 Jian, Inc. has Changed its Name to C3J Therapeutics, Inc

On November 29, 2016, C3 Jian, Inc. changed its name to C3J Therapeutics, Inc.

David Goesling Joins C3 Jian, Inc. as Vice President, Finance & Accounting

C3 Jian, Inc. announced that David Goesling has joined the company as Vice President, Finance & Accounting. Mr. Goesling has over 30 years of financial and accounting experience with rapidly-growing companies focused on disruptive technologies. Most recently, he was an independent consultant for emerging growth companies in the biotech and technology industries. Prior to that, Mr. Goesling was the CFO of RF Surgical Systems, a venture capital backed medical device company. Prior to joining RF Surgical, he held finance and accounting positions with increasing levels of responsibility in the telecom industry.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
December 7, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact C3J Therapeutics, Inc., please visit www.c3jtherapeutics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.